Genetics of drug transformation

Area of Science:

• Pharmacogenetics
• Biochemistry

Background:

• Drug metabolism is influenced by genetic factors.
• Genetic deficiencies in cytochrome P-450 enzymes and aldehyde dehydrogenase have been identified.
• These deficiencies can alter drug processing and clinical outcomes.

Purpose of the Study:

• To highlight the discovery of genetic deficiencies in drug metabolism.
• To discuss the clinical significance of these metabolic defects.
• To explain the role of genetic variations in aldehyde dehydrogenase and ethanol metabolism.

Main Methods:

• Observation of drug biotransformations and urinary metabolites.
• Identification of genetic deficiencies in drug-metabolizing enzymes.
• Analysis of aldehyde dehydrogenase isozymes and their substrate affinity.

Main Results:

• Recessive deficiencies in debrisoquine/sparteine and mephenytoin metabolism were discovered.
• Approximately 40% of the Oriental population lack a high-affinity acetaldehyde dehydrogenase isozyme.
• This deficiency leads to higher acetaldehyde concentrations and associated symptoms like flushing.

Conclusions:

• Genetic variations significantly affect drug metabolism.
• Defects in drug-metabolizing enzymes have clinical implications.
• Understanding these genetic differences is crucial for personalized medicine and drug safety.